The aim of the study was to evaluate left atrial (LA) mechanical functions in MS before and after percutaneous mitral balloon valvuloplasty (PMBV) and to follow it up in short-and mid-term.
L eft atrial (LA) functions consist of conduit, reservoir, and pump function. [1, 2] Reservoir function occurs during left ventricular (LV) systole when the mitral valve is closed, the LA is relaxed, and the mitral annulus is temporarily displaced toward the apex. [3] The LA acts as a conduit in diastole, when the mitral leaflets open and allow blood to enter the left ventricle (LV). At end-diastole, the LA contracts, and the pump function occurs. [4] Several diseases have been acknowledged as pathological causes for mitral valve stenosis, among them rheumatic heart disease is the most prevalent. Rheumatic heart disease is a manifestation of rheumatic carditis, which occurs in 60% to 90% cases of rheumatic fever. [5] Rheumatic mitral stenosis (MS) is associated with a considerable fusion of the commissures, reduction of the mitral valve apparatus, and leaflet mobility. In MS, LA dimension increases and LA pump function deteriorates as time elapsed. [6] [7] [8] Percutaneous mitral balloon valvuloplasty (PMBV) is a procedure that has been revealed to be an alternative to open and closed commissurotomy in the management of MS, currently the most common valvular disease. Short-, mid-, and long-term results obtained from management with PMBV in patients with appropriate symptomatic and mitral morphology demonstrated that this treatment modality is as effective as surgical procedures. [9] Successful PMBV decreases the intensity of spontaneous LA contrast, reduces the size of the LA, and improves LA function.
[10] Improvements in LA mechanical functions after PMBV have been demonstrated in few clinical studies. The studies in the literature have evaluated only the mechanical functions of the LA in the early period following PMBV, and no improvement has been noted in the pump functions of the LA in the acute phase.
The aim of the present study was to evaluate shortand mid-term effects of PMBV on the mechanical functions of LA. In addition to other mechanical functions, the present study particularly evaluated the pump functions in mid-term, which do not recover in the acute phase.
PATIENTS AND METHODS
We designed a prospective observational study to investigate post-PMBV impact on LA mechanical functions in MS.
Subject
A total of 49 consecutive patients (male/ female 14/35; mean age 42±11 years) with symptomatic MS after successful PMBV were included in this study. Indications for PMBV were New York Heart class ≥II, ≤IV, planimetered MVA, ≤1.5 cm², mitral regurgitation ≤2+, suitable valve morphology, and the absence of concomitant cardiovascular disease requiring surgical correction. All patients had sinus rhythm. A detailed written informed consent was obtained from all the patients. Approval of the study was obtained from the Local Ethics Committee. Exclusion criteria were as follows: left ventricular ejection fraction (LVEF) <50%, aortic regurgitation greater than a mild degree or aortic stenosis, mitral regurgitation greater than a mild degree, tricuspid stenosis, clinical, echocardiographic or angiographic evidence of coronary artery disease, hypertension, diabetes mellitus, severe calcification of mitral valve annulus, clinical or laboratorical evidence of active rheumatic disease, chronic obstructive or restrictive lung disease, chronic pulmonary thromboembolism, and low-quality echocardiographic images for tissue Doppler imaging or velocity vector imaging analyses.
Transthoracic echocardiography and LA mechanical functions
In this study, a Vingmed system five Doppler echocardiographic (GE Vingmed ultrasound, Horten, Norway) unit with a 2.5 MHz FPA probe was used. All echocardiograms were recorded in left lateral decubitus with the parasternal long and apical 2-chamber and 4-chamber views. Mitral valve area (MVA) was calculated using the equation of continuity and planimetric methods, and the average of the two methods was included in the analysis.
LA volumes were measured echocardiographically at the time of mitral valve opening (maximal, LA max volume), at the onset of atrial systole (p wave in the electrocardiography: LA volume before atrial systole), and in the mitral valve closure (minimal, LA min volume) according to the biplane area-length method in the apical 4-chamber and 2-chamber views. All volumes were corrected for body surface area, and the following LA emptying functions were calculated: [11] 1. LA passive emptying volume = LA max volume −LA volume before atrial systole; 2. LA passive emptying fraction = LA passive emptying volume/LA max volume × 100; 3. LA conduit volume = LV stroke volume (LA max volume − LA min volume); 4. LA active emptying volume = LA volume before atrial systole − LA min volume; 5. LA active emptying fraction = LA active emptying volume/LA volume before atrial systole × 100; 6. LA total emptying volume = (LA max volume − LA min volume); and 7. LA total emptying fraction = LA total emptying volume/LA max volume × 100. All measurements were averaged over three cardiac cycles.
Percutaneous balloon valvuloplasty
MS patients underwent PMBV, which was performed by three investigators. The MVA was calculated using the Gorlin equation. Balloon dilation of the mitral valve was performed using a single balloon dilating technique.
Follow-up
Clinical and echocardiographic evaluations were performed before, and 24-48 h, 3 months, and 1 year after the PMBV. Recurrent stenosis was defined as >50% loss of MVA calculated after the procedure and/or a valve area of 1.5 cm². A major cardiovascular event was defined as death, repeat of balloon valvuloplasty, or the need for mitral valve replacement during the follow-up period.
Statistical analysis
Statistical evaluation was performed using SPSS 15.0 (Statistical Package for the Social Sciences, Chicago, IL, USA). Continuous variables were expressed as mean±standard deviation. The Friedman test was used to compare the consecutive measurements, and the Wilcoxon test was used for the post-hoc analysis. A value of p<0.05 was considered significant.
RESULTS
The baseline clinical and demographic properties of all study subjects are presented in Table 1 . Thirtyfive of the 49 patients that were enrolled in the study were female (71%). The average age of the patients was 42±11 years. Of the patients, only 34 had a past history of ARA, and 11 developed right heart failure. Major cardiovascular events (death, repeat balloon valvuloplasty, or mitral valve replacement) and recurrent stenosis were not observed during the followup period. The results of the invasive hemodynamic measurements are shown in Table 2 . No significant change was observed in the cardiac output following PMBV. Pulmonary capillary wedge pressure, pulmonary artery pressure (PAP), and mean gradient decreased significantly following PMBV, whereas the MVA significantly increased. increased after successful PMBV and in the follow-up period (p<0.01).
DISCUSSION
The present study showed that in patients with MS, successful PMBV improved LA reservoir and conduit functions, but not pump function, in both acute and chronic periods. Similar results were reported in a few clinical investigations. The current study demonstrated incompletely improved LA functions, 24-48 h, 3 months, and 1 year after PMBV. This is the first study indicating that LA functions continue to improve in the short-and mid-term after PMBV.
After PMBV, a substantial decline in transmitral gradient is usually observed. In the present study, a substantial decrease in transmitral gradient after PMBV, followed by a decrease in LA volume and an increase in the conduit volume, was observed, which may represent a close relationship among pressure, A comparison of the evaluated parameters before and after PMBV, measured by transthoracic echocardiography, is presented in Table 3 . The measured MVA had a significant increase after successful PMBV and in the follow-up period (p<0.01). The mean gradient value, PAP, LA diameter, and Wilkins the score significantly decreased after successful PMBV and in the follow-up period (p<0.01). A comparison of PMBV LA mechanic functional parameters before and after PMBV, measured by transthoracic echocardiography, is given in Table 4 . LA maximum volume, minimum volume, atrial presystolic volume, LA passive emptying volume (LAPEV), and LA total emptying volume (LATEV) significantly decreased after successful PMBV and in the follow-up period (p<0.01). However, LA passive emptying fraction (LAPEF), LA active emptying fraction (LAAEF), LA active emptying volume (LAAEV), and LA total emptying fraction (LATEF) were not altered after successful PMBV and in the follow-up period. Conduit volume significantly volume, and function. These LA changes were mainly detected after 24-48 h of PMBV but not as marked after the 12 months, which could be explained by the substantial decrease in mitral valve afterload immediately after PMBV. The improvement in the Wilkins score in the acute phase was caused by increased valve mobility following PMBV. No changes were noted in the other parameters (thickening, calcification, or infravalvular structures).
LA functions have a prognostic clinical impact in several different scenarios. Stefanadis et al. found that PMV significantly decreases LA stiffness and increases LA systolic emptying index and LA stroke. Following PMBV, reservoir function increased in patients with atrial fibrillation, but not in patients with sinus rhythm.
[10] In a study of 337 patients with dilated cardiomyopathy, a 3.8-times higher risk for death and the need for transplantation were observed when LA maximum volume was >68.5 mL/m 2 . [12] LA has prognostic implications in Chagas heart disease patients [13] and in sinus rhythm patients. [14] Vieira et al. [15] demonstrated improvements in LA reverse remodeling, in symptomatic MS patients undergoing PMBV, as analyzed by 2D and 3D echocardiography; and LAEF was observed after 72 h and 12 months of the procedure. Bitigen et al.
[10] evaluated the LA mechanical functions before and after PMBV. Despite their indication of an improvement on conduit volume and reservoir functions, LA functions did not completely recover. In the current study, PMBV enabled a contribution to cardiac functions by decreasing LA volume both in the acute and long term. The researchers observed that LAVmax, LAmin, LA presystolic volume, LATEV, and LAPEV improved, and conduit volume increased following successful PMBV and during the follow-up period. However, LATEF, LAAEV, LAPEF, and LAAEF did not improve following successful PMBV and during the follow-up period. In spite of the clear improvement on the atrial volume function rates after a successful PMBV and 1 year of follow-up, the fact that fractional volume rates did not improve may be thought to be due to the late improvements in anatomical changes such as LA dilatation, fibrosis of the atrial wall, and disorganization of atrial muscle bundles. [16] Such improvements may not have been found because only mid-term follow-up results were available. Improvement in the fractions of the atrial volume can be anticipated in studies evaluating long-term results.
One of the most interesting points in this study The present study indicated that PMBV improved the LA mechanical functions including conduit and reservoir functions in the acute phase, and this favorable effect lasted for 1 year. No improvement was noted in the LA pump functions, and long-term studies are warranted to elucidate long-term effects.
Conflict-of-interest issues regarding the authorship or article: None declared was the fast improvement of LA mechanical function even in the post-PMBV acute period. In mitral valve stenosis, LA dysfunction was found to be associated with increased LA afterload. [17] The rapid decline in the afterload, as well as acute hemodynamic changes occurring immediately after PMBV, can explain this rapid recovery. Similar results have been reported in studies with a follow-up period of 1 year, which suggest that favorable mid-term effects of PMBV on the structural alterations in the LA can be explained by the improvement in the LA contraction and LA chamber stiffness. According to Pamir et al. [18] after the PMBV, the left atrium pressure decreases; however, there was no change in the left ventricle's early diastolic filling fraction; and following the PMBV, the LV-end diastolic pressure increases in an important level. Mohan et al. [19] found that the decrease in atrial contribution in younger patients with MS was lower than that in older patients. While the atrial contraction in young patients recovered, there was no recovery in the LA function in older patients. Younger patients achieved better atrial filling after PMBV. This response was due to the improvement in atrial function, which is better in younger patients. [20] Over the past several years, PMBV has become an accepted alternative to surgery in the treatment of MS. This procedure is highly successful with a low complication rate and significant short-and long-term improvements in both hemodynamics and patient symptoms. [21] [22] [23] Abrupt changes in metabolic and hemodynamic parameters following PMBV have attracted attention of most clinicians, and this has led to a rise in the number of research in this field.
The current study found improvement of LA mechanical functions after successful treatment of MS with PMBV, and the improvement continued for 1 year. MS should be treated not only to avoid pulmonary edema and dysrhythmia, but also to alleviate the negative effect of impaired LA functions.
Limitations
This study included a relatively small number of patients with MS. The parameters used to predict LA mechanical functions were not independent parameters. Imaging methods such as real time 3D echocardiography or deformation analysis were not used. The effect of PMBV on late prognosis could not be evaluated because the follow-up period was only 1 year.
